临床药师参与毛细支气管炎临床路径制定方法及效果分析.docVIP

临床药师参与“毛细支气管炎”临床路径制定方法及效果分析 河南省开封市儿童医院临床药学科 张伟 董懿珍 475000 【摘要】目的：探讨临床药师参与“毛细支气管炎”临床路径实施的方法和效果。方法：临床药师参与临床路径制定后，回顾性分析我院临床路径实施前后第一诊断为“毛细支气管炎”患儿病历，比较临床路径实施前与临床路径实施后的患儿抗菌药物使用情况、住院费用，药品费用，住院天数，探讨临床药师参与临床路径的方法及效果。结果：临床路径实施前后，患儿使用抗菌药物情况之间有统计学差异（P0.01); 患者住院总费用、药品费用和住院天数之间有统计学差异（P0.01或P0.05).临床路径实施后，患者的住院总费用、药品费用和住院天数都明显减少。结论：临床药师参与临床路径制定，规范了患者用药，节约了住院费用和药品费用，缩短了住院天数，对节约治疗成本，切实减轻病人经济负担有重要的意义。 关键词：临床药师 临床路径 毛细支气管炎 The way of clinical pharmacist participating in clinical pathway treating capillary bronchitis and effect analysis Zhang Wei Dong Yizhen Clinical Pharmacy Room Children`s Hospital Kaifeng 475000 [Abstract] Objective To discuss the way and the effect of clinical pharmacist participating in clinical pathway treating capillary bronchitis. Method: After formulating the way clinical pharmacist participating in clinical pathway, we analyzed the case histories with the first diagnosis of capillary bronchitis retrospectively，compared the using of antibacterial agents, hospitalization expenses, medicine expenses and in hospital days before and after clinical pathway, discussed the way and effect of clinical pharmacist participating in clinical pathway. Result: The using of antibacterial agents had statistical difference (P0.01); the hospitalization expenses, medicine expenses and in hospital days had statistical difference (P0.05 or P0.01) before and after clinical pathway, After clinical pathway, the hospitalization expenses, medicine costs and in hospital days were reduced obviously. Conclusion The clinical pharmacist participating in clinical pathway formulating, can standardize drug use for patient, save the hospitalization expenses, medicine costs, short the days in hospital, it had important meaning in economizing the cost of treating, reducing the economic burden to patient. Keyword Clinical pharmacist Clinical pathway Capillary bronchitis 为了规范临床诊疗，控制医疗成本，切实降低医疗费用，促进医疗质量持续改进，卫生部在全国各级医疗单位推广实施临床路径标准化诊疗程序。临床路径（clinical pathway，CP）是指针对某个病种或手术，以循证医学为基础，以预期的治疗效